Robust cost efficacy of a novel, validated screening test at 12-20 Weeks gestation for the prediction of preterm birth (PTB) at or before 32 Weeks in singletons
Objective: Preterm birth (PTB) at or before 32 weeks complicates up to 2 % of United States (US) births and accounts for 80 % of perinatal expenditures in the first year of life. Existing screening tests for PTB performed from 12 weeks to 19 weeks 5 days have receiver operated area under the curve...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
BMJ Publishing Group,
2021-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |